Cancer in IBD: Inflammation, Surveillance, Management

Monday, May 11, 2026

1:20 PM - 2:10 PM ET

Co-Moderator(s)

Emina Huang, MD, MBA

Professor of Surgery, Vice-Chair for Research Department of Surgery
University of Texas Southwestern
University of Texas
Dallas, TX, United States

Disclosure information not submitted.
Vitaliy Poylin, MD, MBA

Director, Section of Colon and Rectal Surgery
Northwestern University Feinberg School of Medicine
Northwestern University Feinberg School of Medicine
Chicago, IL, United States

Disclosure information not submitted.

CME .75 hours
Self-Assessment .75 hours

The etiology, prevalence, surveillance strategies and management of cancer in inflammatory bowel disease is undergoing evolution. This symposia will provide the most current understanding, with evidence-based guidance and structure regarding surveillance and surgical approaches

Learning Objectives:

Upon completion of this activity, participants should be able to:

Explain pathogenesis and etiology in the era of current medical treatments.
Compare and contrast various national and professional society guidelines for surveillance and dysplasia including the evidence basis.
Recognize surgical approaches using real-world experiences.